How Did NCB Achieve a 7-Year Sentence for Three Individuals Involved in Chemical Diversion?
Synopsis
Key Takeaways
Ahmedabad, Jan 12 (NationPress) A Special NDPS Court in Gujarat has sentenced three individuals to seven years of rigorous imprisonment for their involvement in the diversion of pharmaceutical precursors used in illegal drug production, according to an official from the Narcotics Control Bureau (NCB) on Monday.
The court, located in Savarkundla, District Amreli, Gujarat, found Alps Life Sciences Pvt Ltd from Sonipat, Haryana, and its three senior executives guilty. Each was also fined Rs 1.5 lakh, as stated by the NCB official.
The investigation uncovered intentional falsification of manufacturing and export records, highlighting the active participation of senior officials from the company.
The individuals convicted in this case include Sumit Kumar, Managing Director, Sumit Kumar, Store In-charge, Dhanesh Chamoli, Authorized Chief Chemist-cum-Production Manager, along with the company itself, Alps Life Sciences.
The case was pursued under Sections 9A, 25A, 26, 29, 35, and 38 of the NDPS Act, 1985, and relevant provisions of the NDPS (Regulation of Controlled Substances) Order, 2013.
Investigation by the NCB Ahmedabad Zonal Unit focused on the diversion of pseudoephedrine, a controlled substance as per the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985.
A complaint against the accused and the company was submitted to the court on November 24, 2023.
During the legal proceedings, the accused attempted to obtain bail from various judicial bodies, including the Supreme Court of India. However, due to the severity of their actions, the potential transnational impacts of precursor diversion, and the robust evidence provided by the NCB, the bail requests were denied, reinforcing the seriousness of the crime.
This conviction serves as a strong warning that the diversion of pharmaceutical precursors and the abuse of legitimate drug manufacturing processes will not be tolerated. The successful resolution of this case underscores NCB’s professional investigation efforts, inter-agency collaboration, and persistent legal follow-up, further emphasizing its commitment to dismantling drug supply networks.